|
EP0014815A3
(de)
|
1978-12-20 |
1980-10-29 |
Ciba-Geigy Ag |
Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
|
|
US4939240A
(en)
|
1983-03-04 |
1990-07-03 |
Health Research, Inc. |
Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
|
|
US4918164A
(en)
|
1987-09-10 |
1990-04-17 |
Oncogen |
Tumor immunotherapy using anti-idiotypic antibodies
|
|
DE3813821A1
(de)
|
1988-04-22 |
1989-11-02 |
Hoechst Ag |
Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
|
|
US6074650A
(en)
|
1985-06-24 |
2000-06-13 |
Hoechst Aktiengesellschaft |
Membrane anchor/active compound conjugate, its preparation and its uses
|
|
US6024964A
(en)
|
1985-06-24 |
2000-02-15 |
Hoechst Aktiengesellschaft |
Membrane anchor/active compound conjugate, its preparation and its uses
|
|
US4743543A
(en)
|
1985-09-09 |
1988-05-10 |
Coulter Corporation |
Method for enhancing and/or accelerating immunoassay detection of human carcinoma tumor associated antigen in a pathology sample
|
|
US4921790A
(en)
|
1987-04-24 |
1990-05-01 |
Research Corporation |
Tumor specific assay for CA125 ovarian cancer antigen
|
|
US4963484A
(en)
|
1988-01-29 |
1990-10-16 |
Dana-Farber Cancer Institute, Inc. |
Genetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigen
|
|
US5053489A
(en)
|
1988-01-29 |
1991-10-01 |
Dana-Farber Cancer Institute, Inc. |
Genetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigen
|
|
US4914021A
(en)
|
1988-03-04 |
1990-04-03 |
New England Deaconess Hospital Corporation |
Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
|
|
US4921789A
(en)
|
1988-04-20 |
1990-05-01 |
New England Deaconess Hospital Corporation |
Marker for colorectal carcinoma and methods of detecting the same
|
|
JPH02172946A
(ja)
|
1988-12-26 |
1990-07-04 |
Shinetsu Sakusan Vinyl Kk |
カルボン酸アルケニルエステルの製造方法
|
|
US5110911A
(en)
|
1989-11-02 |
1992-05-05 |
Biomira, Inc. |
Human tumor-associated thomsen-friedenreich antigen
|
|
WO1993017715A1
(en)
|
1992-03-05 |
1993-09-16 |
Board Of Regents, The University Of Texas System |
Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
|
|
DE69327229T2
(de)
|
1992-12-11 |
2000-03-30 |
The Dow Chemical Co., Midland |
Multivalente einkettige Antikörper
|
|
US5545532A
(en)
|
1993-02-05 |
1996-08-13 |
Epigen, Inc. |
Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging
|
|
US6310180B1
(en)
|
1993-06-21 |
2001-10-30 |
Vanderbilt University |
Method for synthesis of proteins
|
|
DE4331011A1
(de)
|
1993-09-13 |
1995-03-16 |
Bayer Ag |
Nukleinsäuren-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik
|
|
AUPM446594A0
(en)
|
1994-03-16 |
1994-04-14 |
Csl Limited |
Cytotoxic t-cell epitopes identified within epstein-barr virus
|
|
JPH08248579A
(ja)
|
1995-03-14 |
1996-09-27 |
Mitsubishi Paper Mills Ltd |
ハロゲン化銀写真感光材料及びその処理方法
|
|
US5994294A
(en)
|
1996-02-02 |
1999-11-30 |
Nitromed, Inc. |
Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
|
|
AUPO007396A0
(en)
|
1996-05-24 |
1996-06-20 |
Csl Limited |
Ebv ctl epitopes
|
|
US6251603B1
(en)
|
1996-10-03 |
2001-06-26 |
Ludwig Institute For Cancer Research |
Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample
|
|
AUPO784197A0
(en)
|
1997-07-10 |
1997-08-07 |
Csl Limited |
Treatment of nasopharyngeal carcinoma
|
|
US5965535A
(en)
|
1997-09-12 |
1999-10-12 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
ES2281935T3
(es)
|
1997-10-08 |
2007-10-01 |
The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Antigeno cancerigeno humano ny eso-1/ca6 y gen que codifica para el mismo.
|
|
US6602505B2
(en)
|
1998-04-30 |
2003-08-05 |
University Of Southern California |
Viral chimeras comprised of CAEV and HIV-1 genetic elements
|
|
IL125608A0
(en)
|
1998-07-30 |
1999-03-12 |
Yeda Res & Dev |
Tumor associated antigen peptides and use of same as anti-tumor vaccines
|
|
MXPA01007760A
(es)
|
1999-02-01 |
2003-06-24 |
Eisai Co Ltd |
Compuesto adyuvante inmunologico.
|
|
US20040006242A1
(en)
|
1999-02-01 |
2004-01-08 |
Hawkins Lynn D. |
Immunomodulatory compounds and method of use thereof
|
|
CA2390659C
(en)
|
1999-11-15 |
2010-03-02 |
Ludwig Institute For Cancer Research |
Ny-eso-1 peptide derivatives, and uses thereof
|
|
EP2311951A1
(en)
|
2000-01-28 |
2011-04-20 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
|
|
WO2002000623A2
(en)
|
2000-06-26 |
2002-01-03 |
Neurogen Corporation |
Aryl fused substituted 4-oxy-pyridines
|
|
US6506875B1
(en)
|
2000-09-26 |
2003-01-14 |
Ludwig Institute For Cancer Research |
Isolated peptides which bind to HLA-C molecules and uses thereof
|
|
GB0030067D0
(en)
|
2000-12-11 |
2001-01-24 |
Univ Bristol |
Therapeutic agent
|
|
EP1229043A1
(en)
|
2001-01-30 |
2002-08-07 |
Cyto-Barr B.V. |
Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
WO2003008537A2
(en)
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
|
WO2003047499A2
(en)
|
2001-12-04 |
2003-06-12 |
Ben Gurion University Of The Negev Research And Development Authority |
Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
|
|
WO2003104428A2
(en)
|
2002-01-21 |
2003-12-18 |
Vaccinex, Inc. |
Gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
|
GB0214528D0
(en)
|
2002-06-24 |
2002-08-07 |
Univ Aberdeen |
Materials and methods for induction of immune tolerance
|
|
BR0313154A
(pt)
|
2002-08-12 |
2005-08-02 |
Council The Queensland Inst Of |
Novos lipopeptìdeos imunogênicos que compreendem epitopos de célula t-helper e de célula b
|
|
CN101113178A
(zh)
|
2002-08-12 |
2008-01-30 |
昆士兰医学研究所理事会 |
包含辅助t细胞和细胞毒性t淋巴细胞(ctl)表位的新免疫原性脂肽
|
|
WO2004041849A1
(en)
|
2002-11-07 |
2004-05-21 |
The Council Of The Queensland Institute Of Medical Research |
Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
|
|
US7491395B2
(en)
|
2002-11-20 |
2009-02-17 |
Bestewil Holding B.V. |
Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
|
|
WO2005000870A2
(en)
|
2003-05-30 |
2005-01-06 |
Ludwig Institute Of Cancer Research |
Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof
|
|
JP2007500707A
(ja)
|
2003-07-29 |
2007-01-18 |
リブ−エックス ファーマシューティカルズ，インコーポレイテッド |
ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法
|
|
EP1666056A1
(en)
|
2004-12-06 |
2006-06-07 |
Bestewil Holding B.V. |
Cancer vaccine vesicles
|
|
US20080233143A1
(en)
|
2005-02-07 |
2008-09-25 |
Lipotek Pty Ltd. |
Adjuvanting Material
|
|
FR2881746B1
(fr)
|
2005-02-07 |
2007-04-13 |
Centre Nat Rech Scient |
Epitopes t cd4+des antigenes de latence de type i et ii du virus epstein-barr aptes a etre reconnus par la majorite des individus de la population caucasienne et leurs applications
|
|
US20100129385A1
(en)
|
2005-02-08 |
2010-05-27 |
Jackson David C |
Immunogenic molecules
|
|
GB0507003D0
(en)
|
2005-04-06 |
2005-05-11 |
Molmed Spa |
Therapeutic
|
|
AU2006247471A1
(en)
|
2005-05-12 |
2006-11-23 |
Tapestry Pharmaceuticals, Inc. |
Molecular constructs suitable for targeted conjugates
|
|
CA2620899A1
(en)
|
2005-10-12 |
2007-04-19 |
Biolipox Ab |
Benzoxazoles useful in the treatment of inflammation
|
|
JP4824389B2
(ja)
|
2005-10-28 |
2011-11-30 |
株式会社医学生物学研究所 |
エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途
|
|
WO2007065215A1
(en)
|
2005-12-06 |
2007-06-14 |
The Australian National University |
Treatment of epstein-barr virus-associated diseases
|
|
WO2007078879A2
(en)
|
2005-12-21 |
2007-07-12 |
Vaxinnate Corporation |
Lipopeptide compositions and methods of use thereof
|
|
WO2007079448A2
(en)
*
|
2006-01-03 |
2007-07-12 |
University Of Georgia Research Foundation, Inc. |
Three component carbohydrate vaccine
|
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
|
WO2008021296A2
(en)
|
2006-08-14 |
2008-02-21 |
Thymon, L.L.C. |
Compositions and methods for the treatment and prophylaxis of alzheimer's disease
|
|
MX2009007572A
(es)
|
2007-01-15 |
2009-10-13 |
Glaxosmithkline Biolog Sa |
Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y.
|
|
US8309096B2
(en)
|
2007-01-15 |
2012-11-13 |
Glaxosmithkline Biologicals S.A. |
Fusion protein
|
|
EP2462947B1
(en)
|
2007-03-26 |
2019-03-13 |
Academisch Ziekenhuis Leiden h.o.d.n. LUMC |
PRAME derived peptides and immunogenic compositions comprising these
|
|
WO2008151197A2
(en)
|
2007-06-04 |
2008-12-11 |
The Regents Of The University Of California |
Tumor-derived endogenous toll-like receptor 4 ligands
|
|
US20120039984A1
(en)
*
|
2008-07-03 |
2012-02-16 |
University Of Georgia Research Foundation, Inc. |
Glycopeptide and uses thereof
|
|
US20110262473A1
(en)
|
2008-07-07 |
2011-10-27 |
The University Of Melbourne |
Synthetic vaccine component
|
|
US20100266623A1
(en)
|
2008-07-07 |
2010-10-21 |
The University Of Melbourne |
Synthetic, self adjuvanting vaccines
|
|
WO2010028246A2
(en)
|
2008-09-05 |
2010-03-11 |
Id Biomedical Corporation Of Quebec |
Novel compositions and adjuvants
|
|
US8436015B2
(en)
|
2008-09-15 |
2013-05-07 |
Merck Sharp & Dohme Corp. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
|
JP2012523379A
(ja)
*
|
2009-04-09 |
2012-10-04 |
ザ ユニバーシティー オブ メルボルン |
免疫原性組成物およびその使用
|
|
GB0917090D0
(en)
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
WO2011063272A1
(en)
|
2009-11-23 |
2011-05-26 |
Amgen Inc. |
Amino heteroaryl compounds as beta-secretase modulators and methods of use
|
|
EP2504315A1
(en)
|
2009-11-23 |
2012-10-03 |
Amgen Inc. |
Amino heteroaryl compounds as beta-secretase modulators and methods of use
|
|
US20130045203A1
(en)
|
2010-03-02 |
2013-02-21 |
Emory University |
Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
|
|
US10238734B2
(en)
|
2010-03-23 |
2019-03-26 |
The Regents Of The University Of California |
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
|
|
US20130029358A1
(en)
|
2010-04-01 |
2013-01-31 |
Ludwig Institute For Cancer Research Ltd. |
Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof
|
|
WO2011156686A2
(en)
|
2010-06-11 |
2011-12-15 |
The Regents Of The University Of Colorado, A Body Corporate |
Method for synthesizing a cyclic multivalent peptide using a thiol-mediated reaction
|
|
WO2012020215A1
(en)
|
2010-08-09 |
2012-02-16 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
|
|
ES2655535T3
(es)
|
2010-08-25 |
2018-02-20 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Una vacuna contra el virus de Epstein-Barr
|
|
US20140086888A1
(en)
|
2010-09-01 |
2014-03-27 |
Helen E. Heslop |
Ebv-specific cytotoxic t-lymphocytes for the treatment of locoregional nasopharyngeal carcinoma (npc)
|
|
BR112013005970A2
(pt)
|
2010-09-14 |
2016-07-05 |
Council Scient Ind Res |
imunógeno sintético, últil para gerar imunidade duradoura e proteção contra patógenos.
|
|
AU2011304728A1
(en)
|
2010-09-20 |
2013-03-14 |
Biontech Ag |
Antigen-specific T cell receptors and T cell epitopes
|
|
WO2012037612A1
(en)
|
2010-09-22 |
2012-03-29 |
The University Of Melbourne |
Novel immunostimulatory method
|
|
WO2012069188A1
(en)
|
2010-11-24 |
2012-05-31 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V |
Continuous flow processes for photoconjugation of high-molecular chemical entities
|
|
US9187534B2
(en)
|
2011-03-11 |
2015-11-17 |
Universite De Geneve |
Multi-epitopic vaccine
|
|
US9402916B2
(en)
|
2011-03-17 |
2016-08-02 |
The University Of Birmingham |
Re-directed immunotherapy
|
|
CN103534235A
(zh)
|
2011-05-13 |
2014-01-22 |
南洋理工大学 |
用于有机分子修饰的方法
|
|
US20120328660A1
(en)
|
2011-06-03 |
2012-12-27 |
Tsuji Takemasa |
Immunogenic compositions useful in provoking an integrated response to tumor antigens
|
|
CN102839186A
(zh)
|
2011-06-21 |
2012-12-26 |
上海生物制品研究所有限责任公司 |
表达ny-eso-1重组耻垢分枝杆菌的制备及应用
|
|
GB201114051D0
(en)
|
2011-08-15 |
2011-09-28 |
Domainex Ltd |
Compounds and their uses
|
|
WO2013036543A2
(en)
|
2011-09-10 |
2013-03-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Molecular imaging of cancer cells in vivo
|
|
NL2007536C2
(en)
|
2011-10-05 |
2013-04-08 |
Academisch Ziekenhuis Leiden Lumc |
Adjuvant compound.
|
|
CN113876945A
(zh)
|
2011-10-06 |
2022-01-04 |
免疫疫苗技术有限公司 |
包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
|
|
US9056141B2
(en)
|
2012-05-31 |
2015-06-16 |
Synchem, Inc. |
Thiol-ene click chemistry for drug conjugates
|
|
US9861702B2
(en)
|
2012-10-22 |
2018-01-09 |
Wisconsin Alumni Research Foundation |
Lipid-conjugated rhamnose for immune system recruitment and oncotherapy
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
CN105555756B
(zh)
|
2013-06-28 |
2018-12-07 |
奥克兰联合服务有限公司 |
氨基酸缀合物和肽缀合物及缀合方法
|
|
US10253062B2
(en)
|
2014-12-23 |
2019-04-09 |
Margaret Anne Brimble |
Amino acid and peptide conjugates and uses thereof
|
|
US11464853B2
(en)
|
2016-02-26 |
2022-10-11 |
Auckland Uniservices Limited |
Amino acid and peptide conjugates and conjugation process
|